Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125837661 | 12583766 | 1 | I | 20160713 | 20160722 | 20160722 | EXP | ES-ELI_LILLY_AND_COMPANY-ES201607009372 | ELI LILLY AND CO | 50.00 | YR | M | Y | 0.00000 | 20160722 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125837661 | 12583766 | 1 | PS | ERBITUX | CETUXIMAB | 1 | Unknown | U | 125084 | /wk | |||||||||
| 125837661 | 12583766 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | U | 0 | /wk | |||||||||
| 125837661 | 12583766 | 3 | C | SIROLIMUS. | SIROLIMUS | 1 | Unknown | UNK UNK, UNKNOWN | U | 0 | |||||||||
| 125837661 | 12583766 | 4 | C | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 8 MG, QD | U | 0 | 8 | MG | QD | ||||||
| 125837661 | 12583766 | 5 | C | TACROLIMUS. | TACROLIMUS | 1 | UNK | U | 0 | ||||||||||
| 125837661 | 12583766 | 6 | C | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | Unknown | 1 MG, UNKNOWN | U | 0 | 1 | MG | QD | ||||||
| 125837661 | 12583766 | 7 | C | EVEROLIMUS | EVEROLIMUS | 1 | Unknown | UNK UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125837661 | 12583766 | 1 | Squamous cell carcinoma of head and neck |
| 125837661 | 12583766 | 2 | Squamous cell carcinoma of head and neck |
| 125837661 | 12583766 | 3 | Immunosuppression |
| 125837661 | 12583766 | 4 | Immunosuppression |
| 125837661 | 12583766 | 6 | Immunosuppression |
| 125837661 | 12583766 | 7 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125837661 | 12583766 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125837661 | 12583766 | Malignant neoplasm progression | |
| 125837661 | 12583766 | Mucosal inflammation | |
| 125837661 | 12583766 | Neutropenia | |
| 125837661 | 12583766 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125837661 | 12583766 | 3 | 201205 | 0 | ||
| 125837661 | 12583766 | 4 | 201201 | 201205 | 0 | |
| 125837661 | 12583766 | 6 | 201201 | 201205 | 0 |